Kyle Cole

Kyle Cole is a Principal Scientist and Lab Head in Proteomics at Sanofi, with a robust background in biomolecular sciences and proteomics. Prior experience includes roles as Scientist II at Monte Rosa Therapeutics and Research Scientist I at C4 Therapeutics, Inc., where responsibilities focused on advanced proteomic studies. Kyle began a career in the patent field as a Patent Scientist at Foley & Lardner LLP. Academically, Kyle holds a Doctor of Philosophy in Chemistry/Chemical Biology from Boston College, a Master of Science in Chemistry/Biophysical Chemistry from the University of Connecticut, and a Bachelor of Science in Chemistry/Molecular and Cellular Biology, also from the University of Connecticut.